Kenneth M. Izumi

4.3k total citations · 1 hit paper
30 papers, 3.6k citations indexed

About

Kenneth M. Izumi is a scholar working on Oncology, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, Kenneth M. Izumi has authored 30 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 13 papers in Pathology and Forensic Medicine and 11 papers in Physiology. Recurrent topics in Kenneth M. Izumi's work include Viral-associated cancers and disorders (20 papers), Lymphoma Diagnosis and Treatment (13 papers) and Histiocytic Disorders and Treatments (10 papers). Kenneth M. Izumi is often cited by papers focused on Viral-associated cancers and disorders (20 papers), Lymphoma Diagnosis and Treatment (13 papers) and Histiocytic Disorders and Treatments (10 papers). Kenneth M. Izumi collaborates with scholars based in United States, France and Japan. Kenneth M. Izumi's co-authors include Elliott Kieff, Kenneth M. Kaye, George Mosialos, Odile Devergne, Joan B. Mannick, Jonathan S. Stamler, Koichiro Asano, J G Stevens, Ellen Cahir McFarland and Eudoxia Hatzivassiliou and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Kenneth M. Izumi

29 papers receiving 3.6k citations

Hit Papers

Epstein-Barr virus latent membrane protein 1 is essential... 1993 2026 2004 2015 1993 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenneth M. Izumi United States 22 2.5k 1.2k 1.2k 994 819 30 3.6k
Pankaj Trivedi Italy 29 1.3k 0.5× 853 0.7× 851 0.7× 176 0.2× 586 0.7× 67 2.7k
Bernard Mariamé France 24 916 0.4× 615 0.5× 782 0.7× 196 0.2× 343 0.4× 46 2.3k
Teruhito Yasui Japan 26 857 0.3× 314 0.3× 1.4k 1.1× 250 0.3× 321 0.4× 47 2.6k
Alessandra B. Pernis United States 33 1.3k 0.5× 327 0.3× 2.6k 2.2× 331 0.3× 184 0.2× 61 3.8k
Yaël Mamane Canada 21 939 0.4× 223 0.2× 1.7k 1.4× 172 0.2× 502 0.6× 27 3.5k
Hironobu Asao Japan 35 1.2k 0.5× 167 0.1× 2.6k 2.2× 255 0.3× 314 0.4× 85 4.5k
John G. Monroe United States 46 705 0.3× 325 0.3× 3.6k 3.0× 170 0.2× 239 0.3× 126 5.3k
Roberta Pelanda United States 35 774 0.3× 215 0.2× 3.2k 2.7× 180 0.2× 244 0.3× 84 4.9k
George R. Stark United States 9 2.0k 0.8× 179 0.1× 1.9k 1.6× 74 0.1× 264 0.3× 17 3.5k
Judy Tellam Australia 29 1.0k 0.4× 377 0.3× 791 0.7× 225 0.2× 736 0.9× 40 2.7k

Countries citing papers authored by Kenneth M. Izumi

Since Specialization
Citations

This map shows the geographic impact of Kenneth M. Izumi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth M. Izumi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth M. Izumi more than expected).

Fields of papers citing papers by Kenneth M. Izumi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth M. Izumi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth M. Izumi. The network helps show where Kenneth M. Izumi may publish in the future.

Co-authorship network of co-authors of Kenneth M. Izumi

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth M. Izumi. A scholar is included among the top collaborators of Kenneth M. Izumi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth M. Izumi. Kenneth M. Izumi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Izumi, Kenneth M.. (2004). Epstein-Barr Virus Signal Transduction and B-Lymphocyte Growth Transformation. Progress in molecular and subcellular biology. 36. 269–288. 13 indexed citations
2.
Xiong, Anming, et al.. (2004). Epstein-Barr Virus Latent Membrane Protein 1 Activates Nuclear Factor-κB in Human Endothelial Cells and Inhibits Apoptosis. Transplantation. 78(1). 41–49. 27 indexed citations
3.
Izumi, Kenneth M.. (2003). The Yeast Two-Hybrid Assay to Identify Interacting Proteins. Humana Press eBooks. 174. 249–258. 5 indexed citations
4.
Izumi, Kenneth M.. (2001). Identification of EBV transforming genes by recombinant EBV technology. Seminars in Cancer Biology. 11(6). 407–414. 17 indexed citations
5.
Higuchi, Masaya, Kenneth M. Izumi, & Elliott Kieff. (2001). Epstein–Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: Protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors. Proceedings of the National Academy of Sciences. 98(8). 4675–4680. 106 indexed citations
6.
Izumi, Kenneth M., et al.. (1999). Epstein-Barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-κB. Oncogene. 18(49). 6959–6964. 142 indexed citations
7.
Kaye, Kenneth M., Kenneth M. Izumi, Hong Li, et al.. (1999). An Epstein-Barr Virus That Expresses Only the First 231 LMP1 Amino Acids Efficiently Initiates Primary B-Lymphocyte Growth Transformation. Journal of Virology. 73(12). 10525–10530. 68 indexed citations
8.
Devergne, Odile, Ellen Cahir McFarland, George Mosialos, et al.. (1998). Role of the TRAF Binding Site and NF-κB Activation in Epstein-Barr Virus Latent Membrane Protein 1-Induced Cell Gene Expression. Journal of Virology. 72(10). 7900–7908. 201 indexed citations
9.
Izumi, Kenneth M., Kenneth M. Kaye, & Elliott Kieff. (1997). The Epstein–Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation. Proceedings of the National Academy of Sciences. 94(4). 1447–1452. 187 indexed citations
10.
Rochford, Rosemary, Cathy L. Miller, Martin J. Cannon, et al.. (1997). In vivo growth of Epstein-Barr virus transformed B cells with mutations in latent membrane protein 2 (LMP2). Archives of Virology. 142(4). 707–720. 18 indexed citations
11.
Kakizawa, Junko, et al.. (1996). An Outbreak of Norwalk-like Virus Infection in Tokyo and Saitama in Late 1995. Kansenshogaku zasshi. 70(8). 840–841. 1 indexed citations
12.
Kieff, E, Erle S. Robertson, Kenneth M. Izumi, et al.. (1995). Mechanisms of gene regulation and transformation by epstein barr virus. Journal of Cancer Research and Clinical Oncology. 121(S1). S17–S17. 2 indexed citations
13.
Mannick, Joan B., Koichiro Asano, Kenneth M. Izumi, Elliott Kieff, & Jonathan S. Stamler. (1994). Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell. 79(7). 1137–1146. 433 indexed citations
15.
Tsang, S F, F Wang, Kenneth M. Izumi, & Elliott Kieff. (1991). Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression. Journal of Virology. 65(12). 6765–6771. 75 indexed citations
16.
Izumi, Kenneth M. & J G Stevens. (1990). Molecular and biological characterization of a herpes simplex virus type 1 (HSV-1) neuroinvasiveness gene.. The Journal of Experimental Medicine. 172(2). 487–496. 73 indexed citations
18.
19.
Javier, Ronald T., Kenneth M. Izumi, & J G Stevens. (1988). Localization of a herpes simplex virus neurovirulence gene dissociated from high-titer virus replication in the brain. Journal of Virology. 62(4). 1381–1387. 25 indexed citations
20.
Izumi, Kenneth M. & Jack G. Stevens. (1988). Two thymidine kinase deficient herpes simplex viruses exhibit unexpected virulence properties. Microbial Pathogenesis. 4(2). 145–153. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026